Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Liquid ecstasy in general psychiatry: a case series].

Freudenmann RW, Baumgarten E, Hawlik AE, Gahr M, Schönfeldt-Lecuona CJ.

Fortschr Neurol Psychiatr. 2013 Feb;81(2):88-94. doi: 10.1055/s-0032-1330508. Epub 2013 Feb 14. German.

PMID:
23412960
2.

[Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].

van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG.

Ned Tijdschr Geneeskd. 2010;154:A1286. Review. Dutch.

PMID:
21040601
3.

Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study.

Boyd JJ, Kuisma MJ, Randell TT.

Scand J Trauma Resusc Emerg Med. 2012 Feb 1;20:7. doi: 10.1186/1757-7241-20-7.

4.

Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.

McDonough M, Kennedy N, Glasper A, Bearn J.

Drug Alcohol Depend. 2004 Jul 15;75(1):3-9. Review.

PMID:
15225884
5.

Gamma-hydroxybutyrate withdrawal syndrome.

Dyer JE, Roth B, Hyma BA.

Ann Emerg Med. 2001 Feb;37(2):147-53.

PMID:
11174231
6.

Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.

McDaniel CH, Miotto KA.

J Psychoactive Drugs. 2001 Apr-Jun;33(2):143-9.

PMID:
11476261
7.

Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.

van Noorden MS, van Dongen LC, Zitman FG, Vergouwen TA.

Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):394-6. doi: 10.1016/j.genhosppsych.2008.11.001. Epub 2008 Dec 25. Review.

PMID:
19555805
8.

[Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].

Galldiks N, Kadow I, Bechdolf A, Fink GR, Klosterkötter J, Kuhn J.

Fortschr Neurol Psychiatr. 2011 Jan;79(1):21-5. doi: 10.1055/s-0029-1245885. Epub 2010 Dec 9. Review. German.

PMID:
21154180
9.

Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.

Choudhuri D, Cross S, Dargan PI, Wood DM, Ranjith G.

Int J Psychiatry Clin Pract. 2013 Jun;17(2):154-6. doi: 10.3109/13651501.2013.784790. Epub 2013 Apr 12.

PMID:
23485126
10.

Gamma hydroxy butyrate abuse and dependency.

Gonzalez A, Nutt DJ.

J Psychopharmacol. 2005 Mar;19(2):195-204. Review.

PMID:
15871147
11.

[GHB withdrawal delirium].

Stijnenbosch PJ, Zuketto C, Beijaert PJ, Maat A.

Ned Tijdschr Geneeskd. 2010;154:A1086. Dutch.

PMID:
20132572
12.

Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.

Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R.

Am J Addict. 2001 Summer;10(3):232-41.

PMID:
11579621
13.

Gamma-hydroxybutyrate detoxification by titration and tapering.

de Jong CA, Kamal R, Dijkstra BA, de Haan HA.

Eur Addict Res. 2012;18(1):40-5. doi: 10.1159/000333022. Epub 2011 Dec 3.

PMID:
22142784
14.

Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).

Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, Clarke S, Ramsey J, Holt DW, Dargan PI.

QJM. 2008 Jan;101(1):23-9. doi: 10.1093/qjmed/hcm117.

15.

[Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].

Zepf FD, Holtmann M, Duketis E, Maier J, Radeloff D, Schirman S, Wagner A, Poustka F, Wöckel L.

Z Kinder Jugendpsychiatr Psychother. 2009 Sep;37(5):413-20. doi: 10.1024/1422-4917.37.5.413. Review. German.

PMID:
19739059
16.

Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.

Glasper A, McDonough M, Bearn J.

Eur Addict Res. 2005;11(3):152-4.

PMID:
15990433
17.
18.

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.

Galloway GP, Frederick SL, Staggers FE Jr, Gonzales M, Stalcup SA, Smith DE.

Addiction. 1997 Jan;92(1):89-96.

PMID:
9060200
19.

The gamma-hydroxybutyrate withdrawal syndrome.

Tarabar AF, Nelson LS.

Toxicol Rev. 2004;23(1):45-9. Review.

PMID:
15298492
20.
Items per page

Supplemental Content

Write to the Help Desk